Specialised Services clinical commissioning policy: Bortezomib for Relapsed/ Refractory Waldenstrom's Macroglobulinaemia
This activity is now closed…
Unfortunately, this activity is now closed and no more online responses will be accepted.
Unfortunately, this activity is now closed and no more online responses will be accepted.